Fondaparinux Sodium (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Fondaparinux Sodium drug offered from Mylan Institutional LLC. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: fondaparinux sodium
SUBSTANCE NAME: FONDAPARINUX SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2015-01-05
END MARKETING DATE: 0000-00-00


Fondaparinux Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFondaparinux Sodium from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/.5mL)
START MARKETING DATE: 2015-01-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-582_ca7283bf-8d10-4368-866b-b06a316ebed5
PRODUCT NDC: 67457-582
APPLICATION NUMBER: NDA021345

Other FONDAPARINUX SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dr. Reddy’s Laboratories Inc.Fondaparinux Sodium
Dr. Reddy’s Laboratories LimitedFondaparinux Sodium
Mylan Institutional LLCFondaparinux Sodium
Physicians Total Care, Inc.ARIXTRA